Search for a command to run...
Promoter, Institution, and Public shareholding in Anuh Pharma shows no change YoY or QoQ, indicating stagnation in interest.
Sector averages also reflect no change across all categories, signaling a lack of momentum in the Pharma sector overall.
With no buying activity from smart money and a stable sector, investors should exercise caution as the stock follows a lackluster trend.
Category | Trend | Sep 2023 | Dec 2023 | Mar 2024 | Jun 2024 | Sep 2024 | Dec 2024 | Mar 2025 | Jun 2025 |
---|---|---|---|---|---|---|---|---|---|
1Promoter44 | 70.61% | 69.96% | 69.92% | 69.93% | 69.93% | 69.93% | 69.93% | 69.93% | |
2Institution | - | - | - | - | - | - | - | - | |
3Public1 | 0.11% | 0.11% | 0.11% | 0.11% | 0.11% | 0.11% | 0.11% | 0.11% |